Arthur Allen, Jean Connors, Stephan Moll and Naomi Yates Explore Key Findings from The RENOVE and APICAT Trials
Anticoagulation Forum shared an inviting post on LinkedIn:
”Just 2 days away! Don’t miss our upcoming webinar: Secondary VTE Prevention: To Reduce or Not to Reduce?
Thursday, August 7 | 12:00 PM ET
We are excited to welcome another expert to our panel: Naomi Yates, PharmD, BCACP, who will join as a moderator to help guide this dynamic conversation on one of the most debated questions in anticoagulation: what’s the right dose, and when should it be reduced?
This live webinar will explore key findings from the RENOVE and API-CAT trials, framed by a historical lens and brought to life by a panel of expert clinicians.
What you’ll learn:
- DOAC dosing strategies for extended secondary VTE prevention
- Evidence-based guidance for individualizing care
- Practical takeaways for real-world treatment
Speakers:
Arthur Allen, PharmD, CACP
Jean Connors, MD
Stephan Moll, MD
Naomi Yates, PharmD, BCACP
There’s still time to register and bring your clinical questions to the panel.”
Register here.
Stay updated on all conferences, webinars and panel discussions on coagulation disorders with Hemostasis Today.
-
Aug 5, 2025, 17:44Brain Haemorrhage: A Critical Awareness Guide by Dr. Dilip S. Kiyawat
-
Aug 5, 2025, 07:09EHJ Issue 46-29 Explores Cardio-Oncology and Ischaemic Syndrome Management – Now Online
-
Aug 5, 2025, 04:46When the Same Risk Can Be a Benefit – The Balance Between Bleeding and Thrombosis
-
Aug 5, 2025, 04:02Julia Rauscher and Cathy Verbraeken Lead EHC Workshop on Best Practices
-
Aug 5, 2025, 02:28Personalized Perioperative Management in Hemophilia: Key Insights from Heghine Khachatryan
-
Aug 5, 2025, 19:27Ming Y Lim Presents the Clot Cases Conference: Model of Advanced Multidisciplinary Thrombosis Care
-
Aug 5, 2025, 18:49Francois Delvoye and Jean‐Philippe Désilles: Neutrophil Activation Affects Acute Ischemic Stroke Clinical Outcomes?
-
Aug 4, 2025, 17:29MADD: First Causal Gene for Quantitative Von Willebrand Disease Discovered
-
Aug 4, 2025, 16:13Nicolas Gendron on TITAN’s Recent Study: Insights on Managing Pregnancy in Antithrombin Deficiency
-
Aug 4, 2025, 01:59Michael Makris Posts Haemophilia Journal Article Reassessing UK Blood Inquiry
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 5, 2025, 17:59Heghine Khachatryan: Honored to Be Part of The WFH Regional Workshop 2025
-
Aug 4, 2025, 05:20NBCA: Alexis’s DVT Diagnosis Came Without Warning - Learn How She Caught It Early
-
Aug 4, 2025, 00:50NBCA: After Losing Her Daughter to a Blood Clot, Charita Fights to Save Others
-
Aug 3, 2025, 18:10Andrew Agwunobi Congrats Dr. Oladipo Cole and The Whole Team at the Connecticut Bleeding Disorder Center
-
Aug 3, 2025, 12:03Elias Bouchi Presents Werfen EEMEA Talks on Hemostasis: Clot Stories Season 3